TransMedics Group, Inc.
TMDX
$122.59
$0.480.39%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 143.54M | 121.62M | 108.76M | 114.31M | 96.85M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 143.54M | 121.62M | 108.76M | 114.31M | 96.85M |
| Cost of Revenue | 55.31M | 49.61M | 47.92M | 45.04M | 36.89M |
| Gross Profit | 88.23M | 72.01M | 60.85M | 69.26M | 59.96M |
| SG&A Expenses | 43.63M | 46.91M | 42.66M | 42.90M | 36.16M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 116.09M | 112.98M | 104.84M | 101.80M | 84.43M |
| Operating Income | 27.44M | 8.64M | 3.92M | 12.51M | 12.42M |
| Income Before Tax | 26.68M | 6.99M | 4.25M | 12.15M | 12.39M |
| Income Tax Expenses | 994.00K | 132.00K | 29.00K | -41.00K | 196.00K |
| Earnings from Continuing Operations | 25.68M | 6.86M | 4.22M | 12.19M | 12.20M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 25.68M | 6.86M | 4.22M | 12.19M | 12.20M |
| EBIT | 27.44M | 8.64M | 3.92M | 12.51M | 12.42M |
| EBITDA | 33.58M | 14.32M | 9.10M | 17.11M | 16.72M |
| EPS Basic | 0.76 | 0.20 | 0.13 | 0.37 | 0.37 |
| Normalized Basic EPS | 0.49 | 0.13 | 0.08 | 0.23 | 0.24 |
| EPS Diluted | 0.70 | 0.20 | 0.12 | 0.35 | 0.35 |
| Normalized Diluted EPS | 0.42 | 0.12 | 0.07 | 0.22 | 0.22 |
| Average Basic Shares Outstanding | 33.72M | 33.59M | 33.44M | 33.12M | 32.76M |
| Average Diluted Shares Outstanding | 39.91M | 35.21M | 35.68M | 35.29M | 34.68M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |